Lindbrook Capital’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
CCM
EAM
EC
CCM
Lindbrook Capital's EVH Position: Q1 2025 in Review
Lindbrook Capital increased its Evolent Health (EVH) stake by 74% in Q1 2025, buying an estimated $15.3K and bringing the position to 3,558 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.
Lindbrook Capital first reported a position in EVH in Q1 2020 and has held it in 21 quarters since. The position peaked at $162K in Q4 2021. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.
- Lindbrook Capital held 3,558 shares of Evolent Health worth $33.7K as of Q1 2025.
- Lindbrook Capital bought 1,516 Evolent Health shares in Q1 2025, an estimated $15.3K.
- Evolent Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1142 holding.
- Lindbrook Capital first reported a position in Evolent Health in Q1 2020 and has held it in 21 quarters since.
- Lindbrook Capital's Evolent Health position peaked at $162K in Q4 2021.
- 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.